Delivery Order SPE2DB22D3501-SPE2DB25FXB25
- Not listed
- The Defense Logistics Agency (DLA) awarded a $30,760.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product used in fertility treatment. This non-set-aside award, issued on July 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $4,146.49 to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product. This firm fixed price delivery order, issued on July 31, 2025, with completion targeted for August 1, 2025, represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award utilized no set-aside designation, indicating it was competitively awarded through standard procurement procedures. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GONAL-F RFF Redi-Ject 900 Unit 1.44ML pharmaceutical product with a ceiling value of $33,834.30. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract was competitively awarded without set-aside provisions, reflecting...
- On July 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,816.93 to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML pharmaceutical products. This firm fixed-price, non-set-aside delivery order is scheduled for completion by July 23, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.43 to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a pharmaceutical product. The contract is firm fixed price with no set-aside designation and was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,325.67 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The award was made through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $385,020.34 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- This is a $16,462.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical supplies with a period of performance through February 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXB25Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,412.50 for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company's comprehensive IDC vehicle enables delivery of a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs and other federal healthcare systems worldwide. This delivery order reflects AmerisourceBergen's continued role in fulfilling specialized pharmaceutical requirements across the Department of Defense and related government health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.4k | 8/27/25 |